1. Nair HKR, et al. International Consensus Document: Use of wound antiseptics in practice. Wounds International. 2023. www.woundsinternational.com
2. Falanga V, Isseroff RR, et al. Chronic wounds. Nat Rev Dis Prim. 2022;8(1):50.
3. Bowers S, Franco E. Chronic Wounds: Evaluation and Management. Am Fam Physician. 2020;101(3):159–66.
4. Alves PJ, et al. Role of antiseptics in the prevention and treatment of infections in nursing homes. Journal of Hospital Infection, 2023:131 (58e69).
5. Wilkinson HN, Hardman MJ. Wound healing: Cellular mechanisms and pathological outcomes. Open Biol. 2020, 10, 200223.
6. Cavallo I, Sivori F, et al. Bacterial Biofilm in Chronic Wounds and Possible Therapeutic Approaches. Biology 2024,13,109. https://doi.org/10.3390/ biology13020109.
7. Percival SL, Vuotto C, et al. Biofilms and wounds: an identification algorithm and potential treatment options. Adv Wound Care (New Rochelle). 2015;4(7):389-397.
8. Flemming HC, Wingender J, et al.. Biofilms: An emergent form of bacterial life.Nat. Rev. Microbiol. 2016, 14, 563.
9. Malone M, Bjarnsholt T, et al. The prevalence of biofilms in chronic wounds: a systematic review and meta-analysis of published data. J Wound Care 2017, 26(1): 20-25.
10. Zhao A, Sun J, Liu Y. Understanding bacterial biofilms: From definition to treatment strategies. Front Cell Infect Microbiol. 2023 Apr 6;13:1137947. doi: 10.3389/fcimb.2023.1137947.
11. Alves P, Barreto R, et al. Update on the role of antiseptics in the management of chronic wounds with critical colonisation and/or biofilm. Int Wound J. 2021;18:342–358.
12. Falcone M, De Angelis B, et al. Challenges in the management of chronic wound infections. J. Glob. Antimicrob. Resist. 2021, 26, 140–147.
13. Babalska ZŁ, Korbecka-Paczkowska M, et al. Wound Antiseptics and European Guidelines for Antiseptic Application in Wound Treatment. Pharmaceuticals (Basel), 2021. 14(12): 1253.
14. Stan J, Kris G, et al. Evaluation of the role of povidone‑iodine in the prevention of surgical site infections. Surgery Open Science, 2023.13: 9-17. https://doi.org/10.1016/j.sopen.2023.03.005.
15. Kean R, McKloud E, et al. The comparative efficacy of antiseptics against Candida auris biofilms. Int J Antimicrob Agents. 2018;52(5):673-677.
16. Baig MS, Banu A, et al. An Overview of Diabetic Foot Ulcers and Associated Problems with Special Emphasis on Treatments with Antimicrobials. Life 2022, 12, 1054. https://doi.org/10.3390/ life12071054.
17. Paul L, Syed A, et al. Povidone iodine in wound healing: A review of current concepts and practices. Int J of Surg, 2017: 44 (260-268). https://doi.org/10.1016/j.ijsu.2017.06.073.
18. Monstrey SJ. Commentary: Addressing the Challenges in Antisepsis: Focus on Povidone Iodine. J Dermatol & Skin Sci. 2022;4(3):14-16.
19. Gwak HC, Han SH, et al. Efficacy of a povidone-iodine foam dressing (Betafoam) on diabetic foot ulcer. Int Wound J. 2020 Feb;17(1):91-99. doi: 10.1111/iwj.13236.
20. Kulkarni SB, et al. Saline dressing versus povidone iodine dressing in chronic diabetic foot ulcer healing: a prospective comparative study. Int Surg J. 2019 May;6(5):1524-1527.
21. Cwajda-Białasik J, Mościcka P, Szewczyk MT. Antiseptics and antimicrobials for the treatment and management of chronic wounds: a systematic review of clinical trials. Postepy Dermatol Alergol. 2022 Feb;39(1):141-151. doi: 10.5114/ada.2022.113807.
22. Ortega-Peña S, Hidalgo-González C, et al. In vitro microbicidal, anti-biofilm and cytotoxic effects of different commercial antiseptics. Int Wound J. 2017. 14(3): 470-9